73 related articles for article (PubMed ID: 21941144)
1. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukemia and its association with mineral homeostasis and duration of inpatient stay.
Elmantaser ME; Young D; Gibson B; Ahmed SF
J Pediatr Hematol Oncol; 2011 Oct; 33(7):516-20. PubMed ID: 21941144
[TBL] [Abstract][Full Text] [Related]
2. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
[TBL] [Abstract][Full Text] [Related]
3. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
4. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
5. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD
J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786
[TBL] [Abstract][Full Text] [Related]
6. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
[TBL] [Abstract][Full Text] [Related]
7. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
8. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
[TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy.
Treepongkaruna S; Thongpak N; Pakakasama S; Pienvichit P; Sirachainan N; Hongeng S
J Pediatr Hematol Oncol; 2009 Nov; 31(11):812-5. PubMed ID: 19801948
[TBL] [Abstract][Full Text] [Related]
11. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
[TBL] [Abstract][Full Text] [Related]
12. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
Guo CY; Halton JM; Barr RD; Atkinson SA
Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
14. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment.
Kennedy DD; Ladas EJ; Rheingold SR; Blumberg J; Kelly KM
Pediatr Blood Cancer; 2005 Apr; 44(4):378-85. PubMed ID: 15622521
[TBL] [Abstract][Full Text] [Related]
16. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
[TBL] [Abstract][Full Text] [Related]
17. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
[TBL] [Abstract][Full Text] [Related]
18. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
[TBL] [Abstract][Full Text] [Related]
19. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
20. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
